Efficacy and Safety of Sinopharm Vaccine for SARS-CoV-2 and breakthrough infections in Iranian Patients with Hemoglobinopathies: A Preliminary Report

BACKGROUND: The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to high morbidity and mortality worldwide. Vaccination against SARS-CoV-2 is a leading strategy to change the course of the COVID-19 pandemic. AIMS OF THE STUDY: Our aim was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Mehran, Zarei, Tahereh, Haghpanah, Sezaneh, Azarkeivan, Azita, Naderi, Maryam, Matin, Sara, Bazrafshan, Asghar, Zahedi, Zohreh, Shirkavand, Afshan, Pishdad, Parisa, De Sanctis, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992638/
https://www.ncbi.nlm.nih.gov/pubmed/35444764
http://dx.doi.org/10.4084/MJHID.2022.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992638/
https://www.ncbi.nlm.nih.gov/pubmed/35444764
http://dx.doi.org/10.4084/MJHID.2022.026

Ejemplares similares